• HOME
• ABOUT
  • MANAGEMENT
  • BOARD OF DIRECTORS
  • SCIENTIFIC AND MEDICAL ADVISORY BOARD
  • ACADEMIC COLLABORATIONS
  • PARTNERSHIPS
• SCIENCE
  • TARGET
  • METABOLIC SYNDROME
  • TYPE 2 DIABETES
  • INSULIN SENSITIZERS
  • NEURODEGENERATION
• PIPELINE
  • MSDC-0160
  • MSDC-0602
  • MARKET
• NEWSROOM
  • NEWS RELEASES
  • IN THE NEWS
  • PUBLICATIONS
  • PRESENTATIONS
  • FACT SHEET
• CONTACT
  • LOCATION
  • CAREERS
  • MEDIA CONTACT

All media inquiries should be directed to:

Molly Watson
Ritz Communications

Office: 413-568-5794
Mobile: 413-454-3926
molly.watson@ritzcommunications.com